American Shared Hospital Services Common Stock (AMS)
Stock · AMEX · Health Care
$1.28as of 10/16/2026
Price chart
Active signals
AMS Signal Track Record
How signals performed across all stocks →What AMS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | +0.9% | 60% | August 14, 2026 |
| Bollinger Band Breakout | 26 | -4.7% | 42% | August 13, 2026 |
| Bollinger Band Breakdown | 17 | +2.6% | 65% | October 5, 2026 |
| 200-Day Moving Average TouchActive now | 12 | +1.1% | 58% | February 3, 2025 |
| Any 20-session window (baseline) | -0.6% | 45% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About AMS
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments: Leasing and Direct Patient Service. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 82
- Website
- ashs.com/
Fundamentals
- 1-day range
- $1.21$1.28
- Market cap
- $9.67M
- P/E (trailing)
- —
- P/E (forward)
- 3.20
- EPS (trailing)
- $-0.26
- Dividend yield
- —
- Beta
- 0.27
- Avg. volume
- 13.0K
- Ex-dividend date
- June 28, 2007
- Dividend pay date
- July 16, 2007
How American Shared Hospital Services Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
American Shared Hospital Services Common Stock Competitors
Chosen by industry and closest market cap.
- AMSAmerican Shared Hospital Services Common Stock$1.28▲ 1.59%Market cap $9.67MP/E —$1.21$2.39
- ADVBAdvanced Biomed Inc. Common Stock$3.98▼ 18.44%Market cap $12.29MP/E 1.53$3.61$24.23
- ACONAclarion Inc. Common Stock$1.85▼ 5.27%Market cap $5.79MP/E —$1.89$9.38
- BGLCBioNexus Gene Lab Corp Common stock$1.2▼ 1.64%Market cap $3.82MP/E —$1.07$5.89
- YDESWYD Bio Limited Warrants$0.599▼ 9.24%Market cap $16.29MP/E —$0.1904$2.5
- MDXHMDxHealth SA Ordinary Shares$0.207▼ 65.73%Market cap $22.50MP/E —$0.4$5.33
- SERASera Prognostics Inc. Class A Common Stock$2.06▲ 1.48%Market cap $78.32MP/E —$1.56$3.95
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| AMS American Shared Hospital Services Common Stock | $9.67M | — | $1.28 | ▲ 1.59% | $1.21$2.39 |
| ADVB Advanced Biomed Inc. Common Stock | $12.29M | 1.53 | $3.98 | ▼ 18.44% | $3.61$24.23 |
| ACON Aclarion Inc. Common Stock | $5.79M | — | $1.85 | ▼ 5.27% | $1.89$9.38 |
| BGLC BioNexus Gene Lab Corp Common stock | $3.82M | — | $1.2 | ▼ 1.64% | $1.07$5.89 |
| YDESW YD Bio Limited Warrants | $16.29M | — | $0.599 | ▼ 9.24% | $0.1904$2.5 |
| MDXH MDxHealth SA Ordinary Shares | $22.50M | — | $0.207 | ▼ 65.73% | $0.4$5.33 |
| SERA Sera Prognostics Inc. Class A Common Stock | $78.32M | — | $2.06 | ▲ 1.48% | $1.56$3.95 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- What Is Behind ams-OSRAM (SWX:AMS) Stock Dropping Today?Yahoo · 10/1/2026
- ams OSRAM (SWX:AMS) Stock Looks Undervalued On Its 150% RunYahoo · 10/1/2026
Insider Activity
Insider Actions →- Raymond C. Stachowiak · July 22, 2026 · Grant220.0K
- Raymond C. Stachowiak · June 22, 2026 · Buy586.5K @ $2.28
Institutional Ownership
March 31, 2026
- Total shares held
- 964.7K
- Total value held
- $1.39M
- Institutional holders
- 20
- Unknown205.1K
- Unknown160.6K
- Unknown153.7K
- Unknown90.8K
- Unknown76.4K
- Unknown49.2K
- Unknown42.3K
- Unknown32.9K
- Unknown32.6K
- Unknown29.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
ams OSRAM stock drops despite recent gains
ams OSRAM shares declined recently, drawing attention to the stock's recent performance. While the company has seen a significant run-up, current trading levels have led some to view the shares as undervalued. The stock is currently trading near its support level, with an analyst target price set at $4.00.
ams OSRAM stock drops despite recent gains. ams OSRAM shares declined recently, drawing attention to the stock's recent performance. While the company has seen a significant run-up, current trading levels have led some to view the shares as undervalued. The stock is currently trading near its support level, with an analyst target price set at $4.00.